Langer, Ellen M.

Modeling tumor phenotypes in vitro with three-dimensional bioprinting

Langer, E. M., Allen-Petersen, B. L., King, S. M., Kendsersky, N. D., Turnidge, M. A., Kuziel, G. M., Riggers, R., Samatham, R., Amery, T. S., Jacques, S. L., et al. (2019) · Cell Reports

3D Printing in Biomedical ResearchCellular Mechanics and Interactions

Cited by 256

Targeting c-MYC by antagonizing PP2A inhibitors in breast cancer

Janghorban, M., Farrell, A. S., Allen-Petersen, B. L., Pelz, C., Daniel, C. J., Oddo, J., Langer, E. M., Christensen, D. J., & Sears, R. C. (2014) · Proceedings of the National Academy of Sciences

Protein Tyrosine PhosphatasesPI3K/AKT/mTOR signaling in cancer

Cited by 186

Differentiation-state plasticity is a targetable resistance mechanism in basal-like breast cancer

Risom, T., Langer, E. M., Chapman, M. P., Rantala, J., Fields, A. J., Boniface, C., Alvarez, M. J., Kendsersky, N. D., Pelz, C. R., Johnson-Camacho, K., et al. (2018) · Nature Communications

Cancer Cells and MetastasisBreast Cancer Treatment Studies

Cited by 174

The tumor suppressor phosphatase PP2A-B56α regulates stemness and promotes the initiation of malignancies in a novel murine model

Janghorban, M., Langer, E. M., Wang, X., Zachman, D., Daniel, C. J., Hooper, J., Fleming, W. H., Agarwal, A., & Sears, R. C. (2017) · PLoS ONE

Protein Tyrosine PhosphatasesHematopoietic Stem Cell Transplantation

Cited by 19